Synthesis and magnetic properties of Fe-doped CdS nanorods

Micro & nano letters

article

Xiaoyan Li¹  Minlong Deng¹  Xue Wang²  Hongfang Li¹  Miao Yu¹ 

[1] National and Local Joint Laboratory of Traffic Civil Engineering Materials, Chongqing Jiaotong University;Department of Applied Physics, Chongqing University;School of Materials Science and Engineering, Chongqing Jiaotong University

关键词: cadmium compounds;    remanence;    semiconductor growth;    nanomagnetics;    iron;    nanorods;    wide band gap semiconductors;    vacancies (crystal);    visible spectra;    X-ray diffraction;    ferromagnetic materials;    photoluminescence;    coercive force;    II-VI semiconductors;    X-ray chemical analysis;    X-ray photoelectron spectra;    semimagnetic semiconductors;    nanofabrication;    ultraviolet spectra;    semiconductor doping;    ab initio calculations;    magnetic properties;    dopants;    Fe-doped CdS nanorods;    hexagonal nanorods;    hydrothermal method;    X-ray diffraction;    energy dispersive X-ray spectroscopy;    UV–visible absorption;    photoluminescence;    X-ray photoelectron spectroscopy;    ferromagnetism;    remanence magnetisation;    coercive field;    first-principle calculations;    nanocrystal;    vacancies;    temperature 293 K to 298 K;    CdSFe;   

DOI  :  10.1049/mnl.2018.5331

学科分类：计算机科学（综合）

来源: Wiley

【 摘 要 】

According to so many previous studies, lack of sufficient information during prescribing steps may lead to medication errors. Thus, the presence of the clinical pharmacist during routine rounding process in the ward with intervention of patient care plan may reduce the probability of adverse drug events (ADEs).This study evaluate role of the clinical pharmacists, as a member of medical team with the physician, on ADEs and report their interventions in the internal medicine unit. This study was designed to compare between two groups of patients, those receiving care from a rounding team (physician, nurse, and clinical pharmacist) (study or intervention group with 51 patient); and those receiving care from a rounding team (physician and nurse, but without any pharmacist) (control group with 49 patient). The primary outcome measure was preventable ADEs and secondary one involves the time of staying in the hospital and onset of response to therapy. Patients were randomly selected, followed a single-blind design, and evaluated by a senior physicians and clinical pharmacists who document their medical interventions.Specialist physicians accepted (60) of (77) recommendations (i.e. do modifications in drug therapy depending on clinical pharmacist interventions). The most common intervention was recommending dosage or frequency of medication (32.4%), followed by addition of medication (19.5%).The rate of preventable ordering ADEs in the study unit was 77% lower than in the control unit (P0.05) in the cost of drug therapy between patient groups. Patients with ADEs in the control group had an average of 1.5 day longer staying period at the hospital; which was not differ significantly (p>0.05) from the study group.In summary, presence of clinical pharmacist during tour as a full member of the patient care team in internal medicine ward was associated with a substantially lowered rate of ADEs which caused by prescribing errors. Types of errors indicate the need for activation of the clinical pharmacist's interventions.

【 授权许可】

CC BY|CC BY-ND|CC BY-NC|CC BY-NC-ND